Reperfusion therapy and mechanical circulatory support in cardiogenic shock;Reperfusionstherapie und mechanische kreislaufunterstutzung bei patienten mit kardiogenem schock

Herz

Volumn 24, Issue 6, 1999, Pages 448-464

  Scholz, Karl H ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Cardiac assist devices; Cardiogenic shock; Hemopump; Intraaortic balloon counterpulsation; Mechanical circulatory support; Myocardial infarction; Percutaneous cardiopulmonary support; Reperfusion therapy

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; CARDIOGENIC SHOCK; COUNTERPULSATION; FIBRINOLYTIC THERAPY; HEART HEMODYNAMICS; HEART MUSCLE REPERFUSION; HUMAN; PATHOPHYSIOLOGY; CARDIOPULMONARY BYPASS; HEART INFARCTION; MORTALITY; REVIEW;

CARDIOPULMONARY BYPASS; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; SHOCK, CARDIOGENIC; THROMBOLYTIC THERAPY;

EID: 0033209036     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03044431     Document Type: Article

References (88)

1. Alonso DR, Scheidt S, Post M, et al. Quantification of myocardial necrosis, clinical, pathologic and electrocardiographic correlations. Circulation 1973;48:588-96.
2. Anderson RD, Ohman EM, Holmes DR, et al. Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I study. J Am Coll Cardiol 1997;30:708-15.
3. Beermann W, Carlsson J, Rustige J, et al. Acute myocardial infarction with cardiogenic shock on admission: Incidence, prognostic implications, and current treatment strategies - results from "The 60-Minutes Myocardial Infarction Project". Herz 1999;24: 369-77.
4. Bengtson JR, Kaplan AJ, Pieper KS, et al. Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. J Am Coll Cardiol 1992;20:1482-9.
5. Berger PB, Holmes DR, Stebbins AL, et al. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue plasminogen activator for Occluded coronary arteries (GUSTO-1) trial. An observational study. Circulation 1997;96:122-7.
6. Bregman D, Nichols AB, Weiss MB, et al. Percutaneous intraaortic balloon insertion. Am J Cardiol 1980;46:261-4.
7. Califf RM, Bengtson JR. Cardiogenic shock. N Engl J Med 1994;330:1724-30.
8. Clauss RH, Birtwell WC, Albertal G, et al. Assisted circulation I.The arterial counterpulsator. J Thorac Cardiovasc Surg 1961;41:447-58.
9. Flameng W. Indications for the use of the Hemopump. In: Flameng W, ed. Temporary cardiac assist with an axial pump system. Darmstadt: Steinkopff, 1991:73-7.
10. Flaherty JT, Becker LC, Weiss JL, et al. Results of a randomized prospective trial of intraaortic balloon counterpulsation and intravenous nitroglycerin in patients with acute myocardial infarction. J Am Coll Cardiol 1985;6:434-46.
11. Gurbel PA, Anderson RD, MacCord CS. Arterial diastolic pressure augmentation by intra-aortic balloon counterpulsation enhances the onset of coronary artery reperfusion by thrombolytic therapy. Circulation 1994;89:361-5.
12. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-401.
13. GISSI-2 The International Study Group. In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomized between alteplase and streptokinase with or without heparin. Lancet 1990;336:71-5.
14. Goldberg RS, Gare JM, Alpert JS. Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975-1988. N Engl J Med 1991;325:1117-22.
15. Grines CL. Aggressive intervention for myocardial infarction: Angioplasty, stents, and intra-aortic balloon pumping. Am J Cardiol 1996;78:Suppl 3A:29-34.
16. Gunnar RM. Cardiogenic shock complicating myocardial infarction. Circulation 1988;78:1508-10.
17. Harnarayan C, Bennett MA, Pentecost BL, et al. Quantitative study of infarcted myocardium in cardiogenic shock. Br Heart J 1970;32:728-32.
18. Hartz R, LoCicero J, Sanders JH, et al. Clinical experience with portable cardiopulmonary bypass in cardiac arrest patients. Ann Thorac Surg 1990;50:437-41.
19. Hering JP, Schröder T, Scholz KH, et al. Myocardial support and protection during regional myocardial ischemia using the hemopump assist device. Thorac Cardiovasc Surg 1991;39:257-62.
20. Hering JP, Scholz KH, Schröder T, et al. Risk of left ventricular loading during percutaneous cardiopulmonary support in cardiac arrest. Coronary Artery Dis 1992;3:419-24.
21. Hochman JS, Boland J, Sleeper LA, et al. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an international registry. Circulation 1995;91:873-81.
22. Holmes DR, Bates ER, Kleiman NS, et al. Contemporary reperfusion therapy for cardiogenic shock: The GUSTO-1 trial experience. J Am Coll Cardiol 1995;3:668-74.
23. Holmes DR, Califf RM, van de Werf F, et al. Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial. Lancet 1997;349:75-8.
24. Ishihara M, Sato H, Tateishi H, Uchida T, et al. Intraaortic balloon pumping as the postangioplasty strategy in acute myocardial infarction. Am Heart J. 1991;122:385-9.
25. Kantrowitz A, Kantrowitz A. Experimental augmentation of coronary flow by retardation of the arterial pressure pulse. Surgery 1953;34:678-87.
26. Kantrowitz A, Tjonneland S, Freed PS, et al. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA 1968;203:113-8.
27. Kennedy JW, Gensini GG, Timmis GC, et al. Acute myocardial infarction treated with intracoronary streptokinase: A report of the Society of Cardiac Angiography. Am J Cardiol 1985;55:871-7.
28. Kern MJ, Aguirre F, Bach R, et al. Augmentation of coronary blood flow by intraaortic balloon pumping in patients after coronary angioplasty. Circulation 1993;87:500-11.
29. KillipT. Cardiogenic shock complicating myocardial infarction. J Am Coll Cardiol 1989;14:47-8.
30. Kovack PJ, Rasak MA, Bates ER, et al. Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock. J Am Coll Cardiol 1997;29:1454-8.
31. Kreuzer H, Bostroem B, Gleichmann U, et al. Der Einfluß der arteriellen Gegenpulsation auf die Hämodynamik des insuffizienten linken Herzens. In: Loogen F. Assistierte Zirkulation. Stuttgart: Thieme, 1967:57-64.
32. Lee L, Bates ER, Pitt B, et al. Percutaneous transluminal angioplasty improves survival in cardiogenic shock complicating acute myocardial infarction. Circulation 1988;78:1345-51.
33. Lee L, Erbel R, Brown TM, et al. Multicenter registry of angioplasty therapy of cardiogenic shock. Initial and long term survival. J Am Coll Cardiol 1991;17:599-603.
34. Maroko PN, Bernstein EF, Lippy P. Effects of intraaortic balloon counterpulsation on the severity of myocardial ischemic injury following acute coronary occlusion. Circulation 1972;45: 1150-9.
35. Merhige ME, Smalling RW, Cassidy DB, et al. Effect of the Hemopump left ventricular assist device on regional myocardial perfusion and function: Reduction of ischemia during coronary occlusion. Circulation 1989;80:Suppl III:III-158-66.
36. Moosvi AR, Khaja F, Villanueva L, et al. Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol 1992;19:907-14.
37. Mooney MR, Arom KV, Joyce LD, et al. Emergency cardiopulmonary bypass support in patients with cardiac arrest. J Thorac Cardiovasc Surg 1991;101:405-54.
38. Moulopoulos S, Topas S, Kolff J. Diastolic balloon pumping (with carbon dioxide) in the aorta: a mechanical assistance to the failing circulation. Am Heart J 1962;63:669-75.
39. Mueller HS. Role of intra-aortic counterpulsation in cardiogenic shock and acute myocardial infarction. Cardiology 1994;84: 168-74.
40. Mundth ED. Surgical treatment of cardiogenic shock and of acute mechanical complications following myocardial infarction. Cardiovasc Clin 1977;8:241-63.
41. Nachlas MM, Sieband MP. The influence of diastolic augmentation on infarct size following coronary artery ligation. J Thorac Cardiovasc Surg 1967;53:698-710.
42. Nanas JN, Moulopoulos SD. Counterpulsation: Historical background, technical improvements, hemodynamic and metabolic effects. Cardiology 1994;84:156-67.
43. Nash IS, Lorell BH, Fishman RF. A new technique for sheathless percutaneous intraaortic balloon catheter insertion. Cathet Cardiovasc Diagn 1991;23:57-60.
44. Ohman EM, Califf RM, George BS, et al. The use of intraaortic balloon pumping as an adjunct to reperfusion therapy in acute myocardial infarction. Am Heart J 1991;121:895-901.
45. Ohman EM, George BS, White CJ, et al. Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Circulation 1994;90:792-9.
46. O'Rourke MF, Norris RM, Campbell TI, et al. Randomized controlled trial of intraaortic balloon counterpulsation in early myocardial infarction with acute heart failure. Am J Cardiol 1981;47:815-20.
47. Overlie PA, Walter PD, Hurd HP, et al. Emergency cardiopulmonary support with circulatory support devices. Cardiology 1994;84:231-7.
48. Page DL, Caulfield JB, Kastor JA, et al. Myocardial changes associated with cardiogenic shock. N Engl J Med 1971;285:133-7.
49. Pennington DG, Swartz M, Codd JE, et al. Intraaortic balloon pumping in cardiac surgical patients: a nine year experience. Ann Thorac Surg 1982;36:125-31.
50. Phillips SJ, Ballentine B, Slonine D, et al. Percutaneous initiation of cardiopulmonary bypass. Ann Thorac Surg 1983;36:223-5.
51. Prewitt RM, Gu S, Schick U, et al. Intraaortic balloon counterpulsation enhances coronary thrombolysis induced by intravenous administration of a thrombolytic agent. J Am Coll Cardiol 1994;23:794-8.
52. Raithel SC, Swartz MT, Braun PR, et al. Experience with an emergency resuscitation system. Trans Am Soc Artif Intern Organs 1989;35:475-7.
53. Reedy JE, Swartz MT, Raithel SC, et al. Mechanical cardiopulmonary support for refractory cardiogenic shock. Heart Lung 1990;19:514-23.
54. Reichman RT, Joyo CI, Dembitzky WP, et al. Improved patient survival after cardiac arrest usinfg a cardiopulmonary support system. Ann Thorac Surg 1990;49:101-4.
55. Ryan TJ, Anderson JL, Antman EM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1996;28:1328-428.
56. Sanfelippo PM, Baker MH, Ewy HG, et al. Experience with intraaortic balloon counterpulsation. Ann Thorac Surg 1986;41: 36-41.
57. Scheidt S, Wilner G, Mueller H, et al. Intraaortic balloon counterpulsation in cardiogenic shock. - Report of a cooperative clinical trial. N Engl J Med 1973;288:979-84.
58. Scholz KH, Saathoff H, Tebbe U. Intraaortale Ballongegenpulsation bei akutem Myokardinfarkt, ischämischer Linksherzinsuffizienz und therapierefraktärer Angina pectoris. Dtsch Med Wochenschr 1989;114:1821-7.
59. Scholz KH, Tebbe U, Chemnitius M, et al. Transfemoral placement of the left ventricular assist device "Hemopump" during mechanical resuscitation. Thorac Cardiovasc Surg 1990;38:69-72.
60. Scholz KH, Tebbe U, Sold G. et al. Erste klinische Erfahrungen mit dem transfemoral plazierbaren linksventrikulären AssistSystem Hemopump. Intensivmedizin 1990;27:491-7.
61. Scholz KH, Hering JP, Schröder T, et al. Protective effects of the hemopump left ventricular assist device in experimental cardiogenic shock. Eur J Cardio-thorac Surg 1992;6:209-14.
62. Scholz KH, Figulla HR, Bock H, et al. Perkutane Herz-Lungen-Maschine bei PTCA von Risiko- und Notfallpatienten. Dtsch Med Wochenschr 1992;117:127-32.
63. Scholz KH, Schweda F, Schröder T, et al. Effects of percutaneous Hemopump compared with intraaortic balloon counterpulsation during acute myocardial ischemia. J Am Coll Cardiol 1994;22: 403.
64. Scholz KH, Hering JP, Schröder T, et al. Myocardial protective effects of percutaneous cardiopulmonary support in experimental shock. J Am Coll Cardiol 1994;22:441.
65. Scholz KH, Werner GS, Schorn B, et al. Postinfarction left ventricular rupture: Successful surgical intervention after percutaneous cardiopulmonary support during mechanical resuscitation. Am Heart J 1994;127:210-1.
66. Scholz KH, Figulla HR, Schweda F, et al. Mechanical left ventricular unloading during high risk coronary angioplasty. - First use of a new percutaneous transvalvular left ventricular assist device. Cathet Cardiovasc Diagn 1994;31:61-9.
67. Scholz KH, Hering JP, Schröder T, et al. Left ventricular unloading by transvalvular axial flow pumping in experimental cardiogenic shock and during regional myocardial ischemia. Cardiology 1994;84:202-10.
68. Scholz KH, Schröder T, Hering JP, et al. Need for active left ventricular decompression during percutaneous cardiopulmonary support in cardiac arrest. Cardiology 1994;84:222-30.
69. Scholz KH, Figulla HR, Schröder T, et al. Pulmonary and left ventricular decompression by artificial pulmonary valve incompetence during percutaneous cardiopulmonary bypass support in cardiac arrest. Circulation 1995;91:2664-8.
70. Scholz KH. Gegenwärtiger Indikationsbereich zum klinischen Einsatz des perkutanen kardiopulmonalen Bypass. In Scholz KH, Hrsg. Perkutaner kardiopulmonaler Bypass in der interventionellen Kardiologie. Aachen: Shaker, 1996:67-70.
71. Scholz KH, Ragab S, von zur Mühlen F, et al. Complications of intra-aortic balloon counterpulsation. - The role of catheter size and duration of support in a multivariate analysis of risk. Eur Heart J 1998;19:458-65.
72. Scholz KH, Dubois-Rande JL, Urban P, et al. Clinical experience with the percutaneous Hemopump during high-risk coronary angioplasty. Am J Cardiol 1998;82:1107-10.
73. Scholz KH, Ragab S, Aleksic I, et al. Cardiogenic shock following postinfarction ventricular septal defect. Eur Heart J (in press).
74. Scholz KH, Ragab S, Vonhof S, et al. Intraaortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction - Duration of shock to cardiac assist is an independent predictor of short-term outcome. Eur Heart J (in press).
75. Schröder T, Hering JP, Scholz KH, et al. Efficiency of the left ventricle assist device Hemopump in cardiac fibrillation. Br J Anaesth 1992;68:536-9.
76. Shawl FA, Domanski MI, Wish MH, et al. Emergency cardiopul-monary bypass support in patients with cardiac arrest in the catheterization laboratory. Cathet Cardiovasc Diagn 1990;19: 8-12.
77. Smalling RW, Cassidy DB, Barrett R, et al. Improved regional myocardial blood flow, left ventricular unloading, and infarct salvage using an axial-flow, transvalvular left ventricular assist device: A comparison with intraaortic balloon counter-pulsation and reperfusion alone in a canine infarction model. Circulation 1992;85:1152-9.
78. Smalling RW, Sweeney M, Lachterman B, et al. Transvalvular left ventricular assistance in cardiogenic shock secondary to acute myocardial infarction. J Am Coll Cardiol 1994;23:637-44.
79. Stomel RJ, Rasak M, Bates ER. Treatment strategies for acute myocardial infarction complicated by cardiogenic shock in a community hospital. Chest 1994;105:997-1002.
80. Stone G. Primary PTCA in High Risk Patients with Acute Myocardial Infarction. J Invas Cardiol 1995;7:Suppl:12-21.
81. Sturm JT, McGee MG, Fuhrmann TM, et al. Treatment of postoperative low output syndrome with intraaortic balloon pumping: Experience with 419 patients. Am J Cardiol 1980;45:1033-6.
82. Sugimoto JT, Baird E, Bruner C. Percutaneous cardiopulmonary support in cardiac arrest. Trans Amer Soc Artif Int Organs 1991; 37:M282-3.
83. Vogt A, Niederer W, Pfafferoot C, et al. Direct percutaneous transluminal coronary angioplasty in acute myocardial infarction. Predictors of short-term outcome and the impact of coronary stenting. Eur Heart J 1998;19:917-21.
84. Vogt A, Neuhaus KL. Therapie des akuten Myokardinfarkts. -Primäre PTCA oder Thrombolyse? Herz 1999;24:363-8.
85. Wampler RK, Moise JC, Frazier OH, et al. In vivo evaluation of a peripheral vascular access axial flow blood pump. Trans Am Soc Artif Intern Organs 1988;34:450-5.
86. Wampler RK, Frazier OH, Lansing AM, et al. Treatment of cardiogenic shock with the Hemopump left ventricular assist device. Ann Thorac Surg 1991;52:506-13.
87. Waldenberger FR, Wouters P, Wiebalck A, et al. Use of left-ventricular assist with the Hemopump in cardiac surgery. Cardiology 1994;84:211-5.
88. Zeymer U, Reissig M, Neuhaus KL. Einsatz einer perkutan anschließbaren Herz-Lungen-Maschine unter Reanimationsbedingungen im kardiogenen Schock bei akutem Herzinfarkt. Dtsch Med Wochenschr 1993;118:1755-8.